Manufacturing News of Note—Biocon Bengaluru plant gets FDA nod; Samsung, Ichnos Sciences expand agreement

stocks
(Pixabay)

> The FDA has issued an Establishment Inspection Report concluding its investigation of Biocon’s biosimilar plant in Bengaluru, India. Filing (PDF)

> Samsung Biologics has won a long-term manufacturing agreement to produce a treatment for moderate-to-severe atopic dermatitis from Ichnos Sciences if it is approved. Release

> Pharma Logistics has acquired the pharma returns business of competitor Stericycle. Release

> Heraeus Pharmaceutical Ingredients is adding capacity to its plant in Hanau, Germany, to make platinum-based HPAPIs used in cancer chemotherapies Story

> Ingredient distributor Barentz has acquired a majority shareholding in ingredient maker IMCoPharma, which is based in Czech Republic. Release

Suggested Articles

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.

Taro Pharmaceuticals has recalled two lots of a seizure drug because of suspension issues.

Sanofi will unload six manufacturing sites and 3,100 employees into a new API production company as it looks for €2 billion in cost savings.